Malvern & Leukocare collaborate on COVID-19 vaccines
Industry News: Malvern Panalytical & Leukocare collaborate on stabilization and formulation development of COVID-19 vaccines 03 Mar 2021 Malvern Panalytical and Leukocare have announced an exciting collaboration aiming to improve the availability of vaccines for COVID-19. They will combine Leukocare’s pioneering expertise in biopharmaceutical formulation development with Malvern Panalytical’s extensive analytical know-how to understand how the stability of vaccines can be improved, increasing production and simplifying distribution. Dr. Andreas Seidl, Chief Operating Officer at Leukoca...
Source: selectscience.net